Dr Peter Harper

Dr Peter Harper trained at University College and University College Hospital (MB BS 1970) and has been a leading consultant at Guy's and St Thomas Hospital for over 25 years. He is both an accredited physician and a medical oncologist. One of the four founder partners of the London Oncology Clinic, his vision was of a clinic dedicated solely to cancer treatment offering the highest international standards of care in a state-of-the-art supportive environment, also providing the support including all the ancillary care required by patients and their families. Author of more than 400 papers and chapters in peer-reviewed publications, he is acknowledged globally for his work in researching new drugs and developing improved forms of cancer treatment. He has been the chair, or has been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications and is currently a member of eight pharmaceutical company advisory boards and is a member of sixteen professional bodies from around the world, including board membership of a committee of the American Society of Clinical Oncologists (ASCO). In 2002 he was awarded the prestigious Cino del Duca Medal in 2004 in recognition of his work in developing new anti-cancer and vaccine therapies. For his role in advising the French Government in strategic cancer care (Board Member French National Cancer Institute), he was appointed a Chevalier of the Legion D'Honneur, a rare distinction for a foreign national. He remains on the board of INCA, the strategic committee for cancer treatment in France, and is currently the Chairman of the Toulouse Cancer Centre and holds the Medaille D'Or of that city. Diseases, Medical Tests and Treatments • Chemotherapy of solid tumours • Gynaecological cancers • Gastrointestinal cancers • Breast cancer • Lung cancer • Urological cancers • Chemotherapy of solid tumours • Gynaecological cancers • Gastrointestinal cancers • Breast cancer • Lung cancer • Urological cancers

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2017–2023
   MD · Medicine and Surgery

   UAB Barcelona (GB)

2. 2023–2027
   Residency · Oncology

   Universitat de València (GB)

1. 2027-09–2028-08
   Junior consultant

   UAB Barcelona Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 3 · i10: 6

Selected publications

1. Validation of clinical scoring in Oncology

   Dr Peter Harper, et al. · European Journal of Medicine, 2026

   DOI: 10.2651/euroclin.2026.0 · cited by 73

2. Long-term follow-up of Oncology across GB

   Dr Peter Harper, et al. · European Journal of Medicine, 2025

   DOI: 10.3433/euroclin.2025.1 · cited by 51

• Patient education Patient guide to Oncology 2026-03-09 · 8 min read
• Awareness When should you see a oncology? 2026-01-28 · 8 min read